ES2718491T3 - Vacuna para enfermedad intrauterina - Google Patents

Vacuna para enfermedad intrauterina Download PDF

Info

Publication number
ES2718491T3
ES2718491T3 ES13858593T ES13858593T ES2718491T3 ES 2718491 T3 ES2718491 T3 ES 2718491T3 ES 13858593 T ES13858593 T ES 13858593T ES 13858593 T ES13858593 T ES 13858593T ES 2718491 T3 ES2718491 T3 ES 2718491T3
Authority
ES
Spain
Prior art keywords
necrophorum
fimh
cows
coli
ruminant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13858593T
Other languages
English (en)
Spanish (es)
Inventor
Rodrigo Carvalho Bicalho
Robert Owen Gilbert
Vinicius Machado
Marcela Bicalho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell University
Original Assignee
Cornell University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell University filed Critical Cornell University
Application granted granted Critical
Publication of ES2718491T3 publication Critical patent/ES2718491T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/114—Fusobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/18—Arrangements for indicating condition of container contents, e.g. sterile condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
ES13858593T 2012-11-29 2013-10-08 Vacuna para enfermedad intrauterina Active ES2718491T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261731333P 2012-11-29 2012-11-29
PCT/US2013/063866 WO2014084964A1 (en) 2012-11-29 2013-10-08 Vaccine for intrauterine disease

Publications (1)

Publication Number Publication Date
ES2718491T3 true ES2718491T3 (es) 2019-07-02

Family

ID=50828340

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13858593T Active ES2718491T3 (es) 2012-11-29 2013-10-08 Vacuna para enfermedad intrauterina

Country Status (12)

Country Link
US (4) US9533034B2 (ja)
EP (2) EP3545970A1 (ja)
JP (1) JP6301945B2 (ja)
AU (1) AU2013353403B2 (ja)
BR (3) BR112015012288B1 (ja)
CA (1) CA2893072C (ja)
ES (1) ES2718491T3 (ja)
HU (1) HUE043129T2 (ja)
MX (2) MX370397B (ja)
NZ (2) NZ708669A (ja)
RU (1) RU2672589C2 (ja)
WO (1) WO2014084964A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ708669A (en) * 2012-11-29 2019-12-20 Univ Cornell Vaccine for intrauterine disease
MX2017011648A (es) * 2015-03-12 2017-11-02 Zoetis Services Llc Metodos de piolisina y composiciones.
WO2017083367A1 (en) * 2015-11-09 2017-05-18 Epitopix, Llc Polypeptides of fusobacterium and methods of use
KR102474924B1 (ko) 2020-04-22 2022-12-06 영남대학교 산학협력단 대장균 부착 단백질 FimH를 유효성분으로 포함하는 항암 면역 증강용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133172T2 (de) * 1990-06-07 2003-04-30 Bayer Ag Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum
AU675234B2 (en) 1992-06-26 1997-01-30 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
US5455034A (en) * 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
ATE506074T1 (de) 1995-06-07 2011-05-15 Univ Kansas State Actinomyces pyogenes und actinomyces pyogenes/fusobakterium necrophorum impfstoffe zur immunisierung von vieh und schafen
US6669940B2 (en) * 2000-04-25 2003-12-30 Kansas University Research Foundation Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
CN1561389A (zh) * 2001-07-25 2005-01-05 纽约大学 糖基神经酰胺作为用于抗传染病和癌症的疫苗的佐剂的用途
WO2010124085A2 (en) * 2009-04-23 2010-10-28 Cornell University Compositions and methods for preventing and treating uterine disease
NZ708669A (en) * 2012-11-29 2019-12-20 Univ Cornell Vaccine for intrauterine disease

Also Published As

Publication number Publication date
US10821169B2 (en) 2020-11-03
HUE043129T2 (hu) 2019-08-28
CA2893072C (en) 2023-10-03
AU2013353403A1 (en) 2015-07-02
JP2016507479A (ja) 2016-03-10
EP3545970A1 (en) 2019-10-02
RU2672589C2 (ru) 2018-11-16
US20190358311A1 (en) 2019-11-28
US20180236055A1 (en) 2018-08-23
JP6301945B2 (ja) 2018-03-28
EP2925353A4 (en) 2016-08-10
US9533034B2 (en) 2017-01-03
BR122019025362B1 (pt) 2022-07-26
RU2015125646A (ru) 2017-01-10
NZ708669A (en) 2019-12-20
EP2925353A1 (en) 2015-10-07
US20170100473A1 (en) 2017-04-13
MX2019012044A (es) 2020-01-13
WO2014084964A1 (en) 2014-06-05
US9981032B2 (en) 2018-05-29
MX2015006862A (es) 2016-06-29
NZ754388A (en) 2022-05-27
BR112015012288A2 (pt) 2018-02-06
EP2925353B1 (en) 2019-03-13
AU2013353403B2 (en) 2018-04-19
BR122019025365B1 (pt) 2022-07-26
BR112015012288B1 (pt) 2022-07-26
US20150335725A1 (en) 2015-11-26
MX370397B (es) 2019-12-11
CA2893072A1 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
US10821169B2 (en) Vaccine for intrauterine disease
ES2903120T3 (es) Composición y procedimiento para el tratamiento y la prevención de infecciones por enterobacterias
US20060286109A1 (en) Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen
CN113454102A (zh) 非洲猪瘟疫苗
CN104159601A (zh) 弯曲杆菌属免疫原性组合物及其用途
US9669060B2 (en) Compositions for preventing and treating uterine disease
US20220257743A1 (en) Klebsiella vaccine and methods of use
RU2723709C1 (ru) Способ профилактики рота-, коронавирусной инфекции и эшерихиоза крупного рогатого скота
CN107427555B (zh) 使用il-8以增加产奶量和改善哺乳动物中生殖健康并抑制高酮血症的组合物和方法
Zhou et al. Oral immunisation with Taishan Pinus massoniana pollen polysaccharide adjuvant with recombinant Lactococcus lactis-expressing Proteus mirabilis ompA confers optimal protection in mice
ES2753369T3 (es) Vacuna de Campylobacter
RU2065749C1 (ru) Способ профилактики бруцеллеза крупного рогатого скота
Machado Kussler A, Foditsch C, Ganda EK, Oikonomou G, Cheong SH, Gilbert RO, Bicalho RC. Subcutaneous immunization with inactivated bacterial components and purified protein of Escherichia coli, Fusobacterium necrophorum and Trueperella pyogenes prevents puerperal metritis in Holstein dairy cows. PLoS One. 2014 Mar 17; 9 (3): e91734.
JP2007502292A (ja) クリプトスポリジウム・パルブムの抗原と他の病原体の抗原とを含む組成物及びワクチン
CN111265659A (zh) 一种刚地弓形虫纳米材料亚单位疫苗及其制备方法和应用
CN113827716A (zh) 犬瘟热病毒弱毒株、及其制备的疫苗组合物和应用
Bataineh Sheep Whey Protein Concentrate with Anti-helicobacter Pylori Antibodies for Passive Immunotherapy
BR102016016891B1 (pt) Fosfatase ácida recombinante rcp01850 de corynebacterium pseudotuberculosis e seu uso em vacinas de subunidade para a linfadenite caseosa
AU2006200963A1 (en) Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen